Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen

ACS Chemical Biology

Volumn 6, Issue 3, 2011, Pages 252-259

  Yang, Fan ^a   Zheng, Xiu Jing ^a   Huo, Chang Xin ^a   Wang, Yue ^a   Zhang, Ye ^b   Ye, Xin Shan ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBOHYDRATE ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; STN ANTIGEN; SYNTHETIC CARBOHYDRATE VACCINE; THERATOPE; TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; CARBOHYDRATE CONFORMATION; CARBOHYDRATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; STEREOISOMERISM; VACCINATION; VACCINES, SYNTHETIC;

MUS;

EID: 79955597625     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb100287q     Document Type: Article

References (52)

1. Astronomo, R. D., and Burton, D. R. (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat. Rev. Drug Discovery 9, 308-324.
2. Zhu, J., Warren, J. D., and Danishefsky, S. J. (2009) Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience. Expert Rev. Vaccines. 8, 1399-1413.
3. Guo, Z., and Wang, Q. (2009) Recent development in carbohydrate-based cancer vaccines. Curr. Opin. Chem. Biol. 13, 608-617.
4. Carr, A., Rodriguez, E., Arango, M. C., Camacho, R., Osorio, M., Gabri, M., Carrillo, G., Valdes, Z., Bebelagua, Y., Perez, R., and Fernandez, L. E. (2003) Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. J. Clin. Oncol. 21, 1015-1021. (Pubitemid 46594129)
5. Liu, X., Siegrist, S., Amacker, M., Zurbriggen, R., Pluschke, G., and Seeberger, P. H. (2006) Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem. Biol. 1 , 161-164.
6. Kircheis, R., Vondru, P., Nechansky, A., Ohler, R., Loibner, H., Himmler, G., and Mudde, G. C. (2005) SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of sialylTn. Bioconjugate Chem. 16, 1519-1528. (Pubitemid 41681519)
7. Dziadek, S., Kowalczyk, D., and Kunz, H. (2005) Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin. Angew. Chem., Int. Ed. 44, 7624-7630. (Pubitemid 41713730)
8. Dziadek, S., Hobel, A., Schmitt, E., and Kunz, H. (2005) A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response. Angew. Chem., Int. Ed. 44, 7630-7635. (Pubitemid 41713731)
9. Westerlind, U., Hobel, A., Gaidzik, N., Schmitt, E., and Kunz, H. (2008) Synthetic vaccines consisting of tumor-associated MUC1 gly- copeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response. Angew. Chem., Int. Ed. 47, 7551-7556.
10. Lo-Man, R, Vichier-Guerre, S., Perraut, R., Deriaud, E., Huteau, V., BenMohamed, L., Diop, O. M., Livingston, P. O., Bay, S., and Leclerc, C. (2004) Afully synthetic therapeutic vaccine candidate targeting carcinoma- associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res. 64, 4987-4994. (Pubitemid 38924547)
11. Ingale, S., Wolfert, M. A., Gaekwad, J., Buskas, T., and Boons, G.J. (2007) Robust immune responses elicited by a fully synthetic three- component vaccine. Nat. Chem. Biol. 3, 663-667. (Pubitemid 47417705)
12. Bundle, D. R., Rich, J. R., Jacques, S., Yu, H. N., Nitz, M., and Ling, C. (2005) Thiooligosaccharide conjugate vaccines evoke antibodies specificfor native antigens. Angew. Chem., Int. Ed. 44, 7725-7729. (Pubitemid 41759536)
13. Buskas, T., Li, Y. H., and Boons, G. J. (2004) The immuno- genicityofthe tumor-associated antigen Lewis(y) maybe suppressed by a bifunctional cross-linker required for coupling to a carrier protein. Chem.-Eur.J. 10, 3517-3524.
14. Zhu, J., Wan, Q., Lee, D., Yang, G., Spassova, M. K., Ouerfelli, O., Ragupathi, G., Damani, P., Livingston, P. O., and Danishefsky, S. J. (2009) From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine. J. Am. Chem. Soc. 131 , 9298-9303.
15. Guttormsen, H., Paoletti, L. C., Mansfield, K. G., Jachymek, W., Jennings, H. J., and Kasper, D. L. (2008) Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc. Natl. Acad. Sci. U.SA. 105, 5903-5908. (Pubitemid 351758470)
16. Jennings, H. J., Roy, R., and Gamian, A. (1986) Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J. Immunol. 137, 1708-1713. (Pubitemid 16014828)
17. Krug, L. M., Ragupathi, G., Kenneth, K. N., Hood, C., Jennings, H. J., Guo, Z., Kris, M. G., Miller, V., Pizzo, B., Tyson, L., Baez, V., and Livingston, P. O. (2004) Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. Clin. Cancer Res. 10, 916-923. (Pubitemid 38198890)
18. Pon, R. A., Khieu, N. H., Yang, Q. L., Brisson, J. R., and Jennings, H. J. (2002) Serological and conformational properties of E. coli K92 capsular polysaccharide and its N-propionylated derivative both illustrate that induced antibody does not recognize extended epitopes of polysialic acid: implications for a comprehensive conjugate vaccine against groups B and C N. meningitides. Can. J. Chem. 80, 1055-1063. (Pubitemid 35370513)
19. Dube, D. H., and Bertozzi., C. R. (2003) Metabolic oligosac- charide engineering as a tool for glycobiology. Curr. Opin. Chem. Biol. 7, 616-625. (Pubitemid 37315799)
20. Lemieux, G. A., and Bertozzi, C. R. (2001) Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem. Bio. 8, 265-275. (Pubitemid 32296116)
21. Liu, T., Guo, Z., Yang, Q., Sad, S., and Jennings, H. J. (2000) Biochemical engineering of surface 2-8 polysialic acid for immunotargeting tumor cells. J. Biol. Chem. 275, 32832-32836.
22. Zou, W, Borrelli, S., Gilbert, M., Liu, T., Pon, R. A., and Jennings, H. J. (2004) Bioen gineering of surface GD3 ganglioside for immunotargeting human melanoma cells. J. Biol. Chem. 279, 25390-25399. (Pubitemid 38756796)
23. Chefalo, P., Pan, Y., Nagy, N., Guo, Z., and Harding, C. (2006) Efficient metabolic engineering of GM3 on tumor cells by N-phenyla- cetyl-D-mannosamine. Biochemistry 45, 3733-3739.
24. Wang, Q., Ekanayaka, S. A., Wu, J., Zhang, J., and Guo, Z. (2008) Synthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier protein. Bioconjugate Chem. 19, 2060-2067.
25. Holmberg, L., and Sandmaier, B. (2004) Vaccination with theratope (sTn-KLH) as treatment for breast cancer. Expert Rev. Vaccines 3, 655-663. (Pubitemid 39576752)
26. Pinho, S., Marcos, N. T., Ferreira, B. A., Carvalho, S., Oliveira, M. J., Santos-Silva, F., Harduin-Lepers, A., and Reis, C. A. (2007) Biological significance of cancer-associated sialyl-Tn antigen: modulation ofmalignant phenotype in gastric carcinoma cells. Cancer Lett. 249, 157-170. (Pubitemid 46452924)
27. Julien, S., Picco, G., Sewell1, R., Vercoutter-Edouart, A. S., Tarp, M., Miles, D., Clausen, H., Taylor-Papadimitriou, J., and Burchell, J. M. (2009) Sialyl-Tn vaccine induces antibody-mediated tumor protection in a relevant murine model. Br. J. Cancer 100, 1746-1754.
28. Sahabuddin, S, Chang, T. C., Lin, C. C., Jan, F. D., Hsiao, H. Y., Huang, K. T., Chen, J. H., Horng, J. C., Ho, J. A., and Lin, C. C. (2010) Synthesis of N-modified sTn analogs and evaluation of their immunogeni- cities by microarray-based immunoassay. Tetrahedron 66, 7510-7519.
29. George, S. K., Schwientek, T., Holm, B., Reis, C. A., Clausen, H., and Kihlberg, J. (2004) Chemoenzymatic synthesis of sialylated glyco- peptides derived from mucins and T-Cell stimulating peptides. J. Am. Chem. Soc. 123, 11117-11124.
30. Keil, S., Claus, C., Dippold, W., and Kunz, H. (2001) Towards the development of antitumor vaccines: a synthetic conjugate of a tumor-associated MUC1 glycopeptide antigen and a tetanus toxin epitope. Angew. Chem., Int. Ed. 40, 366-369. (Pubitemid 32114878)
31. Schwarz, J. B., Kuduk, S. D., Chen, X. T., Sames, D., Glunz, P. W., and Danishefsky, S.J. (1999) A broadly applicable method for the efficient synthesis of 0l-O-linked glycopeptides and clustered sialic acid residues. J.Am. Chem. Soc. 121, 2662-2673. (Pubitemid 29165502)
32. Bernstein, M. A., and Hall, L. D. (1980) A general synthesis of model glycoproteins: coupling of alkenyl glycosides to proteins, using reductive ozonolysis followed by reductive amination with sodium cyanoborohydride. Carbohydr. Res. 78, C1-C3.
33. Jung, M. (2001) Inhibitors of histone deacetylase as new anticancer agents. Curr.Med. Chem. 8, 1505-1511. (Pubitemid 32894012)
34. Manimala, J. C., Li, Z., Jain, A., VedBrat, S., and Gildersleeve, J. C. (2005) Carbohydrate array analysis of anti-Tn antibodies and lectins reveals unexpected specificities: implications for diagnostic and vaccine development. ChemBioChem 6, 2229-2241.
35. Special issue on "Fluorine in the Life Sciences" (2004) ChemBioChem 5, 557-726.
36. Mulard, L. A., and Glaudemans, C. P.J. (1998) Synthesis oftriand tetrasaccharide fragments ofthe Shigella dysenteriae type 1 O-antigen deoxygenated and uorinated at position 3 ofthe methyl 0 -D-galactopyr- anoside terminus. Carbohydr. Res. 311, 121-133. (Pubitemid 28482944)
37. Mersch, C., Wagner, S., and Hoffmann-Röder, A. (2009) Synthesis of fluorinated analogues of tumor-associated carbohydrate and glycopeptide antigens. Synlett 2167-2171.
38. Wong, T. H., Koganty, R. R. (2000) Process for preparation of glycosides of tumor-associated carbohydrate antigens. U.S. Patent 6013779.
39. Martin, T. J., and Schmidt, R. R (1992) Efficient sialylation with phosphite as leaving group. Tetrahedron Lett. 33, 6123-6126.
40. Kondo, H., Ichikawa, Y., and Wong, C. H. (1992) β-Sialyl phosphite and phosphoramidite: synthesis and application to the chemoenzymic synthesis of CMP-sialic acid and sialyl oligosaccharides. J. Am. Chem. Soc. 114, 8748-8750.
41. Ho, C. Y., Strobel, E., Ralbovsky, J., and Galemmo, R. A., Jr. (2005) Improved solution- and solid-phase preparation of hydroxamic acids from esters. J. Org. Chem. 70, 4873-4875. (Pubitemid 40791720)
42. Meo, C. D., Demchenko, A. V., and Boons, G. J. (2001) A stereoselective approach for the synthesis of 0 -sialosides. J. Org. Chem. 66, 5490-5497.
43. Lin, C. C., Huang, K. T., and Lin, C. C. (2005) N-Trifluo- roacetyl sialyl phosphite donors for the synthesis of o(2-9)oligosialic acids. Org. Lett. 7, 4169-4172.
44. Yan, R.B., Yang, F., Wu, Y.F., Zhang, L.H., and Ye, X.S. (2005) An efficient and improved procedure for preparation of triflyl azide and application in catalytic diazotransfer reaction. Tetrahedron Lett. 46, 8993-8995. (Pubitemid 41711861)
45. Monzavi-Karbassi, B., Cunto-Amesty, G., Luo, P., and Kieber- Emmons, T. (2002) Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20, 207-214. (Pubitemid 34270782)
46. Svennerholm, L. (1957) Quantitative estimation of sialic acids II. Colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
47. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicinch- oninic acid. Anal. Biochem. 150, 76-85. (Pubitemid 16258399)
48. Derisbourg, P., Wieruszeski, J. M., Montreuil, J., and Spik, G. (1990) Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia. Biochem. J. 269, 821-825. (Pubitemid 20236097)
49. Manzella, S. M., Hooper, L. V., and Baenziger, J. U. (1996) Oligosaccharides containing β1, 4-linkedN-acetyl-galactosamine, a paradigm for protein-specific glycosylation. J. Biol. Chem. 271, 12117-12120.
50. Manzella, S. M., Dharmesh, S. M., Cohick, C. B., Soares, M. J., and Baenziger, J. U. (1997) Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immuno- suppressive and contraceptive activities. J. Biol. Chem. 272, 4775-4782.
51. Vliegenthart, J. F. G., Coddeville, B., Strecker, G., Wieruszeski, J. M., van Halbeek, H., Peter-Katalinic, J., Egge, H., and Spik, G. (1992) Heterogeneity of bovine lactotransferrin glycans. Characterization of α-D-Galp-(1-3)-β-D-Gal- and α-NeuAc-(2-6)-β-D-GalpNAc-(1- 4)- β-D-GlcNAc-substituted N-linked glycans. Carbohydr. Res. 236, 145-164. (Pubitemid 23013604)
52. Ogata, S., Chen, A., and Itzkowitz, S. H. (1994) Use of model cell lines to study the biosynthesis and biological role of cancer- associated sialosyl-Tn antigen. Cancer Res. 54, 4036-4044. (Pubitemid 24258106)